Patents by Inventor Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives
    Publication number: 20130225648
    Abstract: Methods for treating cognitive/attention deficit disorders in general using tetrahydroindolone derivatives and analogues, particularly tetrahydroindolone derivatives or analogues in which the tetrahydroindolone derivative or analogue is covalently linked to another moiety to form a bifunctional conjugate are disclosed. More specifically, methods and compositions for treating attention deficit disorder and attention deficit hyperactivity disorders in adults and children as well as mild cognitive impairment and dementia are provided.
    Type: Application
    Filed: February 19, 2013
    Publication date: August 29, 2013
    Applicant: SPECTRUM PHARMACEUTICALS, INC.
    Inventor: Spectrum Pharmaceuticals, Inc.
  • SENSITIZATION OF TUMOR CELLS TO RADIATION THERAPY THROUGH ADMINISTRATION OF ENDOTHELIN AGONISTS
    Publication number: 20130150649
    Abstract: Methods to sensitize tumor cells to radiation therapy through the administration of an endothelin agonist such as the ETB agonist IRL1620.
    Type: Application
    Filed: February 6, 2013
    Publication date: June 13, 2013
    Applicants: Spectrum Pharmaceuticals, Inc., The Board of Trustees of the University of Illinois
    Inventors: The Board of Trustees of the University of Illinois, Spectrum Pharmaceuticals, Inc.
  • METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR CONTRIBUTING TO THE TREATMENT OF CANCERS
    Publication number: 20130102543
    Abstract: Methods, compositions and articles of manufacture for contributing to the treatment of cancers, including solid tumors, are disclosed. The methods, compositions and articles of manufacture can utilize an endothelin B agonist (ETB) to enhance the delivery and resulting efficacy of a chemotherapeutic agent.
    Type: Application
    Filed: December 11, 2012
    Publication date: April 25, 2013
    Applicants: Spectrum Pharmaceuticals, Inc., The Board of Trustees of the University of Illionis
    Inventors: The Board of Trustees of the University of Illinois, Spectrum Pharmaceuticals, Inc.
  • METHODS AND COMPOSITIONS FOR CONTRIBUTING TO THE TREATMENT OF CANCERS
    Publication number: 20130101552
    Abstract: Methods and compositions for contributing to the treatment of cancers, especially ovarian tumors, are disclosed. The methods and compositions utilize an endothelin B agonist (ETB) to enhance the delivery and resulting efficacy of chemotherapeutic agent(s) (e.g., cisplatin and/or cyclophosphamide).
    Type: Application
    Filed: December 7, 2012
    Publication date: April 25, 2013
    Applicants: Spectrum Pharmaceuticals, Inc., The Board of Trustees of the University of Illinois
    Inventors: The Board of Trustees of the University of Illinois, Spectrum Pharmaceuticals, Inc.